At a glance
- Originator Janssen L.P.
- Class Antivirals
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Common cold
Most Recent Events
- 15 Nov 1994 No-Development-Reported for Common cold in Belgium (Intranasal)
- 15 Nov 1994 No-Development-Reported for Common cold in United Kingdom (Intranasal)